Connect with us

Featured Stocks

GrowGeneration Corp (OTCMKTS: GRWG) Getting Stronger. Is Now The Time to Buy?

Published

on

GrowGeneration

GrowGeneration Corp (OTCMKTS: GRWG) is a Denver-based company and one of the larger chains for specialty hydroponic and organic garden centers. The company sells thousands of products which are targeted to the cannabis growers.

Most of the products include advanced lighting technology, organic nutrients, and soils as well as state of the art hydroponic equipment which are used indoors and outdoors by home and commercial growers.

GrowGeneration Price Analysis

GRWG Daily Chart

GrowGeneration has not seen a steady flow in its price over some time now with recent fluctuation whereby the price has fallen to a current $3.42. On 17th May 2019, the stock fell by 3.93% and later corrected by going up (an accountable 8.94%) again.

In general, the stock’s 30-day price stands at $3.74, and the low is $2.53 while the 90-day high happens to be $3.74 and low $2.52.

However, there has been a good sign as volume fell along with the stock, which is an excellent deal as volume has to follow stock.

What makes GrowGeneration Corp Exciting?

As we all know, the cannabis industry is rapidly growing one, and only capable stocks will meet the growing demand. To ensure that the demand is met and expectations exceeded, the Denver-based GrowGeneration Corp is taking every right step steadily.

This year alone, the company has exploded with its buying spree as it made five acquisitions already. The latest addition is GreenLife Garden Supply which has now allowed the stock to expand its number of locations massively.

The GreenLife Garden deal resulted in GrowGeneration having added two locations in New Hampshire and Maine making it a total of five retail as well as warehouse locations in New England market.

Overall, the company has 21 locations that serve both commercial and household customers across the United States. Besides, the latest acquisitions led to an addition of $7 million to the stock’s top line.

In February the company acquired assets of Palm Springs Hydroponics which is an established leader in their market. The addition of Palm Springs was the company’s 7th location in California as well as their 22nd store.

It’s clear to note that the stock has been busy opening up and entering markets with cultivation laws being conducive to growing. Besides, there are places where GrowGen can strategically locate operations in the areas with a high concentration of growers.

Not too long ago, GrowGen purchased some assets of BWGS, LLC with the transaction including the purchase of all BWGS’s inventory and branded products. The acquisition bolsters the company’s ability to supply branded ‘house’ products conveniently to customers.

The deal offered GrowGen with an array of private products to provide the customers and further to have a positive impact on the profitability as well as margins going forward. The expectations seem to be in line from the latest Q1 2019 report.

GrowGen Never Stops

As if that is not enough, GrowGen had earlier (during the year) acquired all assets of Chlorophyll, Inc. – a superstore with more than 20,000 sq. ft. of warehouse and retail space. As the first acquisition of 2019, it added $8 million to the company’s revenue.

Also, the company had opened operations in Nevada with the acquisition of Reno Hydroponics assets. Reno has an array of experience of over 10 years, and it became GrowGen’s 23rd location (2nd in Nevada).

All these acquisitions, among other developments the company has taken, are compounded as to be very positive from the Q1 report of the company. In lights of the Q1 2019 report, the company improved results across all financial areas with a small positive net income.

Generally, the stoke rose by 19% on the news and given that the stock is not that direct in the marijuana business like other firms, it’s indeed doing well and showing great potential going forward.

The Bottom Line

GrowGeneration Corp is committed to meet the demands of the emerging markets in the cannabis industry. The continuous acquisition spree shows that the company has enough in store to become a hit in the market, and with positive Q1 2019 results, it looks like it would be a new dawn for the hydroponic distributor.

For the latest updates on GRWG and the hottest MJ stocks, sign up below!

Disclosure: We have no position in GRWG and have not been compensated for this article.

Image courtesy of Pexels

Continue Reading
3 Comments

3 Comments

  1. Pat

    June 27, 2019 at 3:19 pm

    What is the price

  2. Louise

    September 5, 2019 at 2:15 pm

    How much

Leave a Reply

Your email address will not be published. Required fields are marked *

Featured Stocks

Why Lexaria Bioscience Corp (OTCMKTS:LXRP) Is A Comeback Play

Published

on

Lexaria Bioscience

Lexaria Bioscience Corp (OTCMKTS:LXRP) brightest days lie ahead. The sentiments shared by Chief Executive Officer, Chris Bunka, are slowly coming to fruition, going by recent price action activity. After a steep pullback in 2019, the stock has once again started climbing higher, as investors react to milestones achieved in 2019 that affirm long-term prospects.

Lexaria Bioscience Catalysts and Price Analysis

A confirmation that the global innovator in drug delivery systems achieved almost everything it set out to accomplish in 2019 continues to strengthen market sentiments. The inking of strategic partnerships with Fortune 500 style companies is another development that the management continues to tout.

Likewise, Lexaria Bioscience succeeded in getting its DehydraTECH technology to market, consequently creating an avenue for generating long-term value. The company’s Intellectual Property strategy has also started to pay dividends, affirming what is at stake going forward. Reports that the company is already experiencing an increase in revenues is another catalyst that continues to shore the stock’s sentiments and prospects in the markets.

Lexaria Bioscience has already started bottoming out from all-time lows in what appears to be the development of a positive trend. A 10% plus rally from one-year lows continue to fuel optimism that the stock has clocked a bottom and due for a correction higher.

Standing in the way of the emerging uptrend is the $0.50 mark, which is the immediate short-term resistance level. A rally followed by a close above the…

Continue Reading

Featured Stocks

Helix TCS Stock (OTCMKTS:HLIX): A Fundamentally Attractive Investment

Published

on

Helix TCS stock

Helix TCS Stock (OTCMKTS:HLIX) is turning out to be an interesting pick after a steep pullback in 2019. The stock appears to be trading at a big discount going by the solid fundamentals that support a bounce back from current lows. If you are looking for a company seeing plenty of opportunities on the horizon then Helix TCS stock fits the bill.

Helix TCS Stock Catalysts and Price Analysis

The company is currently ranked at number 32 on the Deloitte Technology 500 fastest growing companies. The impressive rating stems from the company reporting impressive financial results depicted by an 80% increase in revenue and a 39% increase in cash flow from operations.

Likewise, the company has moved to strengthen its prospects in the hemp business by launching the nation’s first hemp tracking system. Similarly, the company has inked a strategic partnership with Alt Thirty Six for the launch of digital payments targeting thousands of dispensaries across the U.S

Reports that Helix TCS BioTrack traceability stem processed over $11 million transactions in the first week of recreational sales attest to what could turn out to be a break out year for the company and its technology.

It thus does not come as a surprise that the company’s stock has started to pick up some steam after a roller coaster 2019. A 10% plus rally since the start of the year affirms renewed investor interest in response to the wave of…

Continue Reading

Featured Stocks

Why OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) Is A Promising Stock In 2020

Published

on

OWC Pharmaceutical Research

In 2020, investors are looking for cannabis stocks that can deliver excellent returns following a disappointing 2019, which saw many pot stocks crash to multiyear lows. OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) stands out as a promising cannabis stock to own in 2020.

About OWC Pharmaceutical Research

The cannabis stock universe is vast, so for investors who may have just come across OWC Pharmaceutical for the first time an introduction of the company is in order.

OWC Pharmaceutical is an Israel-based cannabis research company. It is focused on research and development of cannabis-based medical products. The company’s work currently includes development of cannabis-based treatments for a variety of diseases and disorders such as multiple myeloma, psoriasis and fibromyalgia.

Moreover, OWC Pharmaceutical provides consulting services to both government and private entities in the field of medical cannabis programs.

OWC Pharmaceutical Research exited 2019 on a high note

While 2019 ended up being one of the toughest year for cannabis stocks, OWC Pharmaceutical had strong finish to the year. The stock gained 35% on December 31. Before that, the stock rose 65% on December 30. The back-to-back gains in the final days of 2019 helped OWC Pharmaceutical cut its losses for the year but also signaled improving investor sentiment on the stock heading into the new year.

OWC Pharmaceutical finished 2019 at $0.089, having pulled from a low of $0.0045 at the beginning of December.

What…

Continue Reading

MJ Stocks